Compounds > tazobactam
Page last updated: 2024-09-03

tazobactam and tigecycline

tazobactam has been researched along with tigecycline in 9 studies

Compound Research Comparison

Studies
(tazobactam)		Trials
(tazobactam)		Recent Studies (post-2010)
(tazobactam)		Studies
(tigecycline)		Trials
(tigecycline)		Recent Studies (post-2010) (tigecycline)
1,3271536941,999681,285

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's4 (44.44)24.3611
2020's4 (44.44)2.80

Authors

AuthorsStudies
Choi, JY; Ko, KS; Lee, MY; Park, YK; Peck, KR; Rhee, JY; Shin, JY; Song, JH1
Chan, MC; Chang, TY; Chiueh, TS; Sun, JR; Wang, WY1
Clapson, P; Debien, B; Leclerc, T; Lenoir, B; Perez, JP1
Fortier, LC; Garneau, JR; Valiquette, L1
Chesnel, L; Howland, K; Jacqueline, C1
Ju, YG; Lee, HJ; Lee, MG; Sohn, JW; Yim, HS; Yoon, YK1
Cheng, B; Guo, P; Jia, P; Xu, Y; Yang, Q; Zhang, H; Zhu, Y1
Deng, T; Kong, W; Li, S; Shu, Y; Wu, Y1
Chen, CH; Ho, MW; Hsueh, PR; Ko, WC; Lin, HH; Tseng, KH; Wu, PH1

Reviews

1 review(s) available for tazobactam and tigecycline

ArticleYear
Efficacy, safety, and tolerability of antimicrobial agents for complicated intra-abdominal infection: a systematic review and network meta-analysis.
    BMC infectious diseases, 2023, Apr-21, Volume: 23, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Humans; Intraabdominal Infections; Meropenem; Metronidazole; Network Meta-Analysis; Tazobactam; Tigecycline

2023

Other Studies

8 other study(ies) available for tazobactam and tigecycline

ArticleYear
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis; Republic of Korea

2010
Overexpression of the adeB gene in clinical isolates of tigecycline-nonsusceptible Acinetobacter baumannii without insertion mutations in adeRS.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Male; Membrane Transport Proteins; Middle Aged; Minocycline; Molecular Sequence Data; Mutagenesis, Insertional; Reverse Transcriptase Polymerase Chain Reaction; Tigecycline

2010
[Treatment of a septic shock due to multiresistant Acinetobacter baumannii with tigecycline in combination].
    Annales francaises d'anesthesie et de reanimation, 2007, Volume: 26, Issue:12

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Minocycline; Penicillanic Acid; Piperacillin; Shock, Septic; Tazobactam; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination

2007
Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam.
    BMC infectious diseases, 2014, Jan-15, Volume: 14

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Clostridioides difficile; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Ribotyping; Spores, Bacterial; Tazobactam; Tigecycline; Vancomycin

2014
In vitro activity of ceftolozane/tazobactam in combination with other classes of antibacterial agents.
    Journal of global antimicrobial resistance, 2017, Volume: 10

    Topics: Amikacin; Aztreonam; Cephalosporins; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Tazobactam; Tigecycline

2017
In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane/tazobactam against carbapenem-resistant Acinetobacter baumannii.
    Scientific reports, 2022, 05-09, Volume: 12, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Colistin; Drug Combinations; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Rifampin; Tazobactam; Tigecycline

2022
In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program.
    BMC microbiology, 2022, 10-01, Volume: 22, Issue:1

    Topics: Ampicillin; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftaroline; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Klebsiella pneumoniae; Levofloxacin; Meropenem; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Piperacillin; Tazobactam; Tigecycline

2022
Geographic patterns of antimicrobial susceptibilities for Bacteroides spp. worldwide: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2007-2020.
    International journal of antimicrobial agents, 2023, Volume: 62, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Clindamycin; Humans; Leadership; Meropenem; Microbial Sensitivity Tests; Piperacillin; Tazobactam; Tigecycline

2023